Bacil Pharma Limited (BOM:524516)

Bacil Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	9.74	5.69	28.57	0.41	0.29	2.3
Trading Asset Securities	-	-	-	-	1.91	0.76
Cash & Short-Term Investments	9.74	5.69	28.57	0.41	2.2	3.06
Cash Growth	-38.88%	-80.10%	6788.85%	-81.12%	-28.26%	28.71%
Accounts Receivable	11.09	11.8	-	-	-	-
Other Receivables	-	0.05	0.47	-	-	-
Receivables	11.09	11.85	0.47	-	-	-
Other Current Assets	48.38	-	0.03	0.11	0.09	0.1
Total Current Assets	69.21	17.53	29.07	0.52	2.29	3.16
Property, Plant & Equipment	-	-	-	0.06	0.08	0.11
Long-Term Investments	223.5	242.4	213.57	6.11	2.36	2.36
Long-Term Deferred Tax Assets	4.94	6.19	0.54	0.56	1.17	1.08
Other Long-Term Assets	0	-0	0	-	0	-0
Total Assets	308.13	273.93	256	13.26	11.27	12.72

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	0.7	0.2	0.04	0.04	0	0.11
Accrued Expenses	-	-	-	0.09	0.06	0.02
Short-Term Debt	55.22	-	1.64	0.98	0.21	0.33
Other Current Liabilities	-	25.61	0.01	0.02	0.01	0.02
Total Current Liabilities	55.92	25.8	1.69	1.13	0.28	0.47
Other Long-Term Liabilities	-	-0	0	-	0	-
Total Liabilities	55.92	25.8	1.69	1.13	0.28	0.47

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	139.81	139.7	139.7	58.9	58.9	58.9
Retained Earnings	112.4	108.42	114.61	-53.14	-54.28	-53.03
Comprehensive Income & Other	-	-	-	6.37	6.37	6.37
Shareholders' Equity	252.21	248.13	254.31	12.13	10.99	12.24
Total Liabilities & Equity	308.13	273.93	256	13.26	11.27	12.72

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	55.22	-	1.64	0.98	0.21	0.33
Net Cash (Debt)	-45.48	5.69	26.93	-0.57	1.99	2.73
Net Cash Growth	-	-78.89%	-	-	-27.11%	338.69%
Net Cash Per Share	-4.97	0.41	4.27	-0.10	0.33	0.46
Filing Date Shares Outstanding	12.03	14.35	14.35	5.89	5.89	5.89
Total Common Shares Outstanding	12.03	14.35	14.35	5.89	5.89	5.89
Working Capital	13.29	-8.27	27.39	-0.61	2.01	2.69
Book Value Per Share	20.96	17.29	17.72	2.06	1.87	2.08
Tangible Book Value	252.21	248.13	254.31	12.13	10.99	12.24
Tangible Book Value Per Share	20.96	17.29	17.72	2.06	1.87	2.08
Machinery	-	0.59	0.59	0.55	0.59	0.59

Data Source: S&P Global Market Intelligence Last updated: Oct 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error